Granules

Market Cap (₹ Cr.)

₹13,369

52 Week High

721.00

Book Value

₹133

52 Week Low

360.10

PE Ratio

27.44

PB Ratio

3.90

PE for Sector

37.21

PB for Sector

3.95

ROE

12.57 %

ROCE

18.99 %

Dividend Yield

0.27 %

EPS

₹20.30

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

-0.33 %

Net Income Growth

-21.54 %

Cash Flow Change

-40.52 %

ROE

-31.04 %

ROCE

-21.71 %

EBITDA Margin (Avg.)

-6.94 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	319	327	341	326	355	343	340	337	347	391	384	417	487	458	519	587	563	569	643	620	665	749	838	779	785	739	708	895	917	926	967	1,031	1,016	821	1,011	985	944	854	571
Expenses	262	261	277	256	279	267	265	258	267	312	301	338	409	371	428	496	472	449	498	479	390	547	595	575	559	582	610	698	707	725	778	794	797	664	801	738	751	675	465
EBITDA	56	66	64	70	76	76	75	79	80	79	82	78	78	88	92	91	90	120	145	142	275	202	243	204	226	157	98	197	210	201	189	238	220	157	210	248	193	179	105
Operating Profit %	17 %	20 %	18 %	21 %	21 %	21 %	21 %	22 %	23 %	19 %	19 %	18 %	14 %	16 %	17 %	15 %	16 %	21 %	22 %	22 %	20 %	26 %	29 %	26 %	29 %	20 %	13 %	22 %	23 %	21 %	19 %	23 %	21 %	19 %	21 %	25 %	20 %	20 %	17 %
Depreciation	13	14	14	15	15	16	18	19	18	18	19	20	20	22	23	23	23	25	25	25	26	29	30	30	31	32	32	31	32	35	35	38	38	35	36	36	36	36	35
Interest	7	8	9	10	9	8	8	8	8	8	10	8	6	7	8	7	7	7	7	7	7	6	6	6	6	5	4	3	4	4	8	12	14	15	18	20	20	18	15
Profit Before Tax	36	44	40	45	52	52	48	52	55	53	54	51	51	59	62	60	61	88	113	110	242	168	207	169	190	121	62	163	175	162	146	188	168	107	156	192	137	126	56
Tax	7	14	14	14	14	18	16	17	13	17	17	15	14	21	23	22	16	30	27	31	34	57	55	44	47	31	16	42	44	39	39	50	41	26	37	45	43	31	13
Net Profit	29	30	27	30	33	36	34	35	38	36	36	34	34	40	41	40	41	60	94	88	202	125	154	131	142	90	46	121	129	125	109	140	125	80	116	143	97	94	41
EPS in ₹	1.40	1.49	1.31	1.48	1.61	1.64	1.54	1.62	1.76	1.55	1.55	1.33	1.35	1.56	1.61	1.58	1.63	2.34	3.71	3.48	7.94	4.92	6.24	5.29	5.74	3.63	1.86	4.89	5.21	5.03	4.39	5.75	5.18	3.30	4.80	5.89	4.01	3.87	1.71

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,107	1,568	1,855	2,639	2,824	3,146	3,683	4,373	4,503	5,006
Fixed Assets	522	523	606	660	700	927	985	1,171	1,330	1,324
Current Assets	473	820	833	1,179	1,209	1,475	1,878	2,331	2,318	2,634
Capital Work in Progress	18	35	132	286	333	130	164	211	63	53
Investments	73	89	75	75	506	445	592	597	677	941
Other Assets	493	920	1,042	1,618	1,285	1,644	1,942	2,395	2,433	2,688
Total Liabilities	681	903	971	1,361	1,401	1,335	1,520	1,842	1,804	1,895
Current Liabilities	381	650	775	857	843	847	1,128	1,542	1,594	1,769
Non Current Liabilities	300	253	196	504	558	487	392	300	210	126
Total Equity	425	665	884	1,278	1,423	1,812	2,163	2,531	2,699	3,111
Reserve & Surplus	405	643	861	1,253	1,398	1,786	2,138	2,506	2,675	3,087
Share Capital	20	22	23	25	25	25	25	25	24	24

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	30	58	-73	58	-33	118	-154	114	48	41
Investing Activities	-130	-171	-299	-495	-243	-165	-233	-318	-97	-302
Operating Activities	135	144	190	24	227	495	375	280	664	317
Financing Activities	25	86	36	529	-17	-212	-296	151	-519	26

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Oct 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	42.04 %	42.04 %	42.04 %	41.98 %	41.98 %	41.98 %	41.93 %	42.02 %	42.02 %	42.02 %	42.02 %	41.96 %	41.96 %	41.96 %	38.87 %	38.87 %
FIIs	23.11 %	18.35 %	0.00 %	21.38 %	23.19 %	23.13 %	22.35 %	22.65 %	23.67 %	23.90 %	21.35 %	21.48 %	18.78 %	19.57 %	20.39 %	19.49 %
DIIs	1.50 %	2.86 %	23.95 %	4.34 %	3.97 %	3.03 %	4.32 %	4.23 %	4.76 %	5.03 %	6.68 %	7.06 %	10.16 %	10.70 %	14.12 %	14.86 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	33.36 %	36.76 %	34.01 %	32.30 %	30.85 %	31.85 %	31.40 %	31.10 %	29.56 %	29.05 %	29.95 %	29.50 %	29.10 %	27.76 %	26.62 %	26.78 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,764.45	4,25,929.94	38.00	49,887.17	12.06	9,648	27.35	40.28
Cipla	1,459.25	1,18,825.56	25.74	26,520.66	14.17	4,155	12.95	38.47
Mankind Pharma	2,526.70	1,02,885.42	48.65	10,615.63	19.57	1,942	28.89	46.80
Dr Reddys Laboratories	1,193.45	1,01,290.13	18.97	28,905.40	12.36	5,578	-9.47	32.64
Zydus Life Science	941.80	95,280.30	22.27	19,831.50	13.82	3,831	14.57	32.02
Lupin	2,040.00	92,929.19	35.38	20,141.50	19.94	1,936	73.52	37.01
Aurobindo Pharma	1,219.95	73,119.28	20.05	29,559.25	17.55	3,169	8.65	20.74
Alkem Laboratories	5,577.15	66,062.65	30.38	12,978.42	9.84	1,811	14.16	35.74
Glenmark Pharmaceuticals	1,466.75	42,112.35	-	12,653.09	6.58	-1,831	675.84	30.08
IPCA Laboratories	1,569.15	39,910.21	59.43	7,829.81	22.92	529	80.05	52.38